What type of study is this?

This is a Human Clinical Trial study (also classified as: Phase 3).

November 25, 2025Open Access

Efficacy and safety of Ivarmacitinib in moderate-to-severe atopic dermatitis patients with or without previous systemic treatments: a post-hoc analysis of a phase III trial

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Ivarmacitinib demonstrates good efficacy and a favorable safety profile in moderate-to-severe AD patients, irrespective of previous systemic treatments.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo